|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
9
|
|
pubmed:dateCreated |
2010-9-8
|
|
pubmed:abstractText |
Anaplastic thyroid carcinoma (ATC) is a rare but aggressive solid tumor with a very short survival time even with multimodality treatment. In view of in vitro data and the high rate of p53 mutations in ATC, we have used combined treatment with external beam radiation and docetaxel.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
1945-7197
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
95
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
E54-7
|
|
pubmed:meshHeading |
pubmed-meshheading:20591979-Aged,
pubmed-meshheading:20591979-Antineoplastic Agents,
pubmed-meshheading:20591979-Carcinoma,
pubmed-meshheading:20591979-Cell Differentiation,
pubmed-meshheading:20591979-Chemotherapy, Adjuvant,
pubmed-meshheading:20591979-Combined Modality Therapy,
pubmed-meshheading:20591979-Dose Fractionation,
pubmed-meshheading:20591979-Female,
pubmed-meshheading:20591979-Humans,
pubmed-meshheading:20591979-Male,
pubmed-meshheading:20591979-Middle Aged,
pubmed-meshheading:20591979-Radiotherapy Dosage,
pubmed-meshheading:20591979-Retrospective Studies,
pubmed-meshheading:20591979-Survival Analysis,
pubmed-meshheading:20591979-Taxoids,
pubmed-meshheading:20591979-Thyroid Neoplasms,
pubmed-meshheading:20591979-Treatment Outcome
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
High efficacy of concomitant treatment of undifferentiated (anaplastic) thyroid cancer with radiation and docetaxel.
|
|
pubmed:affiliation |
Department of Internal Medicine I, Division of Oncology and Cancer Center, Medical University of Vienna, A-1010 Vienna, Austria.
|
|
pubmed:publicationType |
Journal Article,
Evaluation Studies
|
